On ECHEMI
Home > Drugs > Yuanda Shuyang Life Science (Chengdu) Co., Ltd.
Yuanda Shuyang Life Science (Chengdu) Co., Ltd.
  • Founded in:

    1985-08-12
  • Country:

    China China
  • Address:

    No. 888, Antai 5th Road, Chengdu Hi-tech Zone
  • Tax NO.:

    91510100202368620M
  • Registered Funds:

    320 million yuan
  • Email:

Related Drugs
Human immunoglobulin
Main ingredients: Human immunoglobulin
Name Description Content CAS NO. Registered Holders
human immunoglobulin

Immunoglobulin injection is a passive immunotherapy that transfers a large amount of antibodies contained in immunoglobulin to the recipient, allowing the recipient to quickly reach a temporary immune protection state from a low or no immune state. The interaction between antibodies and antigens directly neutralizes toxins and kills bacteria and viruses, so it has a certain effect on preventing bacterial and viral infections.

More

Immunoglobulin injection is a passive immunotherapy that transfers a large amount of antibodies contained in immunoglobulin to the recipient, allowing the recipient to quickly reach a temporary immune protection state from a low or no immune state. The interaction between antibodies and antigens directly neutralizes toxins and kills bacteria and viruses, so it has a certain effect on preventing bacterial and viral infections.

0
Human immunoglobulin
Main ingredients: Human immunoglobulin
Name Description Content CAS NO. Registered Holders
human immunoglobulin

Immunoglobulin injection is a passive immunotherapy that quickly transforms a low or no immune state into a temporary immune protection state by infusing a large amount of antibodies into the recipient. The interaction between antibodies and antigens directly neutralizes toxins and kills bacteria and viruses, and has a certain effect on preventing bacterial and viral infections.

More

Immunoglobulin injection is a passive immunotherapy that quickly transforms a low or no immune state into a temporary immune protection state by infusing a large amount of antibodies into the recipient. The interaction between antibodies and antigens directly neutralizes toxins and kills bacteria and viruses, and has a certain effect on preventing bacterial and viral infections.

0
Tetanus immune globulin
This product is a specific immunoglobulin preparation obtained by immunizing with hepatitis B vaccine and then immunizing with tetanus toxoid to obtain healthy human plasma or serum with high tetanus antibody titer. It contains more than 90% of immunoglobulin G. The tetanus antibody titer per 1ml is not less than 100 units. There are two dosage forms: injection and lyophilized product.
Name Description Content CAS NO. Registered Holders
Tetanus Ab

For passive immunization against tetanus, protective antibodies stay in the circulation longer. Intramuscular injection of 250U of this product can maintain the protective level of immunoglobulin (0.01U/ml) for about 4 weeks. It is better than the use of horse antitoxin for the prevention and treatment of tetanus.

More

For passive immunization against tetanus, protective antibodies stay in the circulation longer. Intramuscular injection of 250U of this product can maintain the protective level of immunoglobulin (0.01U/ml) for about 4 weeks. It is better than the use of horse antitoxin for the prevention and treatment of tetanus.

No less than 100Unit/ml 0
IGE, ANTI-HUMAN, GOAT, IGG FRAC, FITC, LQ

Prepared from human plasma, it is used for passive immunization against tetanus with minimal risk of allergic reaction.

More

Prepared from human plasma, it is used for passive immunization against tetanus with minimal risk of allergic reaction.

More than 90%none 0
Rabies immunoglobulin
Human rabies immunoglobulin.
Name Description Content CAS NO. Registered Holders
HUMAN RABIES IMMUNOGLOBULIN BRP

This product is a high titer rabies antibody that can specifically neutralize the rabies virus and play a passive immunization role.

More

This product is a high titer rabies antibody that can specifically neutralize the rabies virus and play a passive immunization role.

0
Hepatitis B immune globulin
Human Hepatitis B Immunoglobulin
Name Description Content CAS NO. Registered Holders
Human Hepatitis B immunoglobulin BRP

This product contains high titer hepatitis B surface antibodies, which can specifically bind to the corresponding antigens to play a role in passive immunity.

More

This product contains high titer hepatitis B surface antibodies, which can specifically bind to the corresponding antigens to play a role in passive immunity.

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.